Unknown

Dataset Information

0

A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response.


ABSTRACT: BACKGROUND: Tuberculosis (TB) is one of the most prevalent infectious diseases affecting millions worldwide. The currently available anti-TB drugs and vaccines have proved insufficient to contain this scourge, necessitating an urgent need for identification of novel drug targets and therapeutic strategies. The disruption of crucial protein-protein interactions, especially those that are responsible for virulence in Mycobacterium tuberculosis - for example the ESAT-6:CFP10 complex - are a worthy pursuit in this direction. METHODS: We therefore sought to improvise a method to attenuate M. tuberculosis while retaining the latter's antigenic properties. We screened peptide libraries for potent ESAT-6 binders capable of dissociating CFP10 from ESAT-6. We assessed the disruption by a peptide named HCL2, of the ESAT-6:CFP10 complex and studied its effects on mycobacterial survival and virulence. RESULTS: We found that HCL2, derived from the human cytochrome c oxidase subunit 3 (COX3) protein, disrupts ESAT-6:CFP10 complex, binds ESAT-6 potently, disintegrates bacterial cell wall and inhibits extracellular as well as intracellular mycobacterial growth. In addition, an HCL2 expressing M. tuberculosis strain induces both Th1 and Th17 host protective responses. CONCLUSIONS: Disruption of ESAT-6:CFP10 association could, therefore, be an alternate method for attenuating M. tuberculosis, and a possible route towards future vaccine generation.

SUBMITTER: Samuchiwal SK 

PROVIDER: S-EPMC4089558 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response.

Samuchiwal Sachin Kumar SK   Tousif Sultan S   Singh Dhiraj Kumar DK   Kumar Arun A   Ghosh Anamika A   Bhalla Kuhulika K   Prakash Prem P   Kumar Sushil S   Bhattacharyya Maitree M   Moodley Prashini P   Das Gobardhan G   Ranganathan Anand A  

BMC infectious diseases 20140701


<h4>Background</h4>Tuberculosis (TB) is one of the most prevalent infectious diseases affecting millions worldwide. The currently available anti-TB drugs and vaccines have proved insufficient to contain this scourge, necessitating an urgent need for identification of novel drug targets and therapeutic strategies. The disruption of crucial protein-protein interactions, especially those that are responsible for virulence in Mycobacterium tuberculosis - for example the ESAT-6:CFP10 complex - are a  ...[more]

Similar Datasets

| S-EPMC10653824 | biostudies-literature
| S-EPMC7603755 | biostudies-literature
2023-09-22 | PXD045586 | Pride
| S-EPMC1346617 | biostudies-literature
| S-EPMC5009273 | biostudies-literature
| S-EPMC10653941 | biostudies-literature
| S-EPMC3345088 | biostudies-literature
| S-EPMC2694998 | biostudies-literature
| S-EPMC5787779 | biostudies-literature
| S-EPMC2397374 | biostudies-literature